Phlbi.org

Mesothelioma Survivor Profile: Tony Chomo

 

OF NOTE:  PHLBI IS EXTREMELY GRATEFUL TO TONY AND JANET CHOMO FOR THEIR NUMEROUS DONATIONS TO SUPPORT DR. ROBERT CAMERON’S MESOTHELIOMA RESEARCH EFFORTS AT THE PUNCH WORTHINGTON RESEARCH LABORATORY AT UCLA, FUNDED BY PHLBI.

 

Tony Chomo and his wife, Janet, moved from Massachusetts to California in 1977. The day finally came when Tony, a career maintenance worker and licensed plumber, had all he could take of the brutal East Coast winters. The family, now consisting of four grown children and nine grandchildren, settled in Simi Valley.

In August 2006, Tony was involved in a motorcycle accident. But, his injuries seemed minor, and Tony went home. One month later, he found himself having a hard time breathing normally.  Tony went to the emergency room at Northridge Hospital. An EKG ruled out a heart attack, but fluid was found surrounding his lung, and was drained.  Tests on the fluid revealed abnormal mesothelial cancer cells, and Tony was diagnosed was malignant pleural mesothelioma.

A friend told Tony about Dr. Robert Cameron at UCLA’s David Geffen School of Medicine, and Tony met Dr. Cameron in October 2006.  For Tony, the eternal optimist, the family provider, the rock of stability who could nonetheless let loose on the open road atop 1200cc’s of  motorcycle muscle, the options seemed slim, until Dr. Cameron talked about treating mesothelioma as a chronic condition which Tony would have to deal with the remainder of his life—like high blood pressure or diabetes. The focus became choosing a treatment that would hopefully extend his life and allow him to maintain his quality of life. 

Dr. Cameron: “I told Tony that his disease appeared to be limited just to that part of the chest and did not have obvious spread to his lymph nodes. He was a good candidate for the pleurectomy with decortication procedure done, so I recommended that.”  Tony had the pleurectomy with decortication surgery on January 9, 2007.  Dr. Cameron, removed all visible tumor attached to Tony’s chest cavity and organs. Tony required ten days of recovery in the hospital.  Tony responded reasonably well.  Many people have problems with abnormal heart rhythms, pain, coughing up phlegm, and that kind of thing. But he seemed to get through that reasonably well.  He’s a pretty strong person. Then Tony did radiation on the body. What’s really tricky about radiation is that you technically want to radiate every place where the tumor was present. But that involves every single surface of the lung, the diaphragm, the middle of the chest and the ribs. That’s a big area. Also, the lung itself is very sensitive to radiation damage. So you have to have a lot of fancy treatment planning to be able to deliver radiation to all those areas and yet not hurt the lung.”

Tony is proud to say he has not taken any prescription pain medication since February 2007. He feels soreness and occasional numbness at the incision site but manages it without medication. In June 2007 he finished radiation with Dr. Michael Selch at UCLA. By July 2007 he started the next phase of treatment, daily injections of interferon alpha. Initially he felt tired and fatigued from the injections, but this has since improved.

In November 2007, Tony grew concerned when a CT scan revealed possible fluid in the lower left lung.  However, tests determined it was not fluid development, but rather air that had accumulated, resulting in a partial collapse of one lung.  Inflammation due to radiation was still visible, but this has since improved, as well. There is currently no sign that the cancer has spread.  Tony has monthly comprehensive blood tests along with scans and the Mesomark blood test every three months.

Tony tries to go on walks two to three days a week to stay active. He tires easily and notices significantly decreased breathing capacity. He loves riding his motorcycle with his buddies whenever he gets a chance and has gone on several bike rides with a friend in the mountains and in Ojai.

A Loving Couple

Tony and Jan continue their active and adventurous lifestyle. They own Harley-Davidson and Suzuki motorcycles and enjoy taking the motorcycles on tours and trips. Prior to becoming motorcycle enthusiasts, they owned boats and would go scuba diving. A seasoned dirt bike rider, Tony enjoys the thrill of showing his grandchildren how to ride off-road.  And, no job or occupation is as dear to Tony as the role of “Grandpa” and babysitter.  The Chomos’ home is constantly filled with the laughter and chatter of rambunctious youngsters.

Prior to his diagnosis, Tony had no plans of retiring, but since his surgery and radiation, Tony made the decision to cut out work completely, which was one of the hardest adjustments. Tony’s life has changed, but he faces those changes with fortitude and optimism. His surgery has given him the precious gift of time, which he lovingly spends with his children, grandchildren, and great-grandchildren.

In his own words: Dr. Cameron describes the benefit of Pleurectomy/Decortication (PD) surgery over Extra-Pleural Pneumonectomy (EPP) surgery

Much debate and research exists regarding these two methods of surgical resection in treating mesothelioma. Because no randomized clinical studies have been conducted to compare P/D to EPP, much of the survival data, quality of life issues, even the techniques behind the surgeries remain unproven. Dr. Robert Cameron favors sparing the lung utilizing the Pleurectomy with Decortication surgery. He tells us why: 

 

“When performing surgery for malignant pleural mesothelioma, no matter how meticulous a surgeon might be, they will never be able to completely resect (remove) every last cancer cell — that is impossible. They are going to leave tumor cells in the chest no matter what they do.  Proponents of the radical, highly invasive EPP surgery want to tell a patient they ‘got it all’,  but in fact, that is never the case, and removing a vital organ (a lung) underneath the tumor that has nothing to do with getting all the tumor out is sacrificing vital function that greatly increases the risks of the operation.  Sacrificing vital function of a lung increases the risk of dying during the surgery and increases the risk of complications later on. Why cause problems where there are no problems already?  My philosophy has always been: ‘do no harm.’  Taking out a lung does harm and there is absolutely no benefit to the patient.

 

Another advantage of P/D over EPP is that P/D allows you to limit the operation site to the areas of tumor. By performing EPP, your surgeon may expand your surgery into new places where there is no tumor, and that will just spread the tumor.  In P/D, we leave barriers up (diaphragm, pericardium, chest wall) between tumors and other areas so we don’t spread it.

 

Doing a bigger operation makes no sense from an oncology standpoint, because a surgeon cannot rid a mesothelioma patient of every last cancer cell and cure them – that won’t happen.  Once you accept that, then you can understand why P/D is the best surgical option with the least side effects, the least chance of dying and a better chance of getting as much tumor clearance as possible.” 

 

 

Watch Dr. Cameron’s presentation to the Society of Cardiothoracic Surgeons: Interferon Alpha 2b injections may prolong life expectancy for mesothelioma patients

PRESENTATION TOPIC: Maintenance therapy for malignant mesothelioma to inhibit new cancerous tumors from forming and possibly extending the time between recurrences. When combined with surgery and radiation, Dr. Robert Cameron reports prolonged life expectancy to 37 months on average.  Click here to watch his presentation: Presentation Link

BACKGROUND:

What is interferon?

A protein produced naturally by the body’s immune system which helps fight infections and viruses.  Interferon alpha in particular fights infection and also prevents tumor formation.

One reason tumors grow in the body is because blood vessels bring nutrients to them.  Mesothelioma is a cancer known to cause many new blood vessels to form allowing multiple and diffuse tumors to grow and spread through the body.  Interferon alpha prevents new blood vessels from growing, which in turn starves tumors and limits their growth.

using interferon as maintenance therapy for mesothelioma may extend a patient’s life. 

Dr. Robert Cameron of UCLA has been treating malignant pleural mesothelioma patients with a daily low dose of interferon alpha since 2002.  Each night before going to sleep, the patient self-injects with a small dose of interferon alpha.  If, over time, the body tolerates the medication well, Dr. Cameron may slowly increase the dose.

Common side effects:

  • Flu-like symptoms (fever, muscle pain, joint pain, headache, chills)
  • Fatigue and low energy levels
  • Discomfort related to food and digestion
  • Loss of appetite, nausea or vomiting
  • Diarrhea
  • Dizziness or confusion
  • Mood disturbances such as depression
  • Other possible changes such as hair thinning, skin discomfort or rash, dry mouth, or altered sense of taste
  • Numbness in the hands or feet
  • Autoimmunity

Warning to females of childbearing age: This medicine is not usually given during pregnancy. Use reliable birth control during this treatment. Contact your health care provider right away if you become pregnant during treatment. Do not breastfeed during treatment with this medicine.

Warning to diabetics: This medicine may worsen diabetes, but rarely. Contact your health care provider if your condition changes.

When taken with other medicines, interferon can change the way this or any of the other medicines work. Also, using multiple medicines together might cause harmful side effects. Talk to your health care provider, especially if you are taking any of these medicines:

  • theophylline and aminophylline
  • zidovudine (Retrovir, AZT)

Be sure to tell all health care providers who treat you about all medicines you are taking, including nonprescription products, vitamins, and natural remedies. And remember to keep all medicines out of the reach of children. Do not share medicines with other people.

Is Interferon Alpha 2b right for you?

Have your Doctor contact Dr. Robert Cameron at (310) 231-2130 for more information.

FYI:  The Schering Plough Commitment to Care program offers financial assistance to qualified patients:

For some, there may be financial assistance through the Schering Plough Commitment to Care program.  In the U.S. complete your application by downloading this Commitment to Care Application and mailing it to:

Commitment to Care, Oncology Program
6900 College Blvd., Suite 1000
Overland Park, KS 66211

Or via Fax: (866) 277-9328
Questions? Call (800) 521-7157. 

In Canada, call (877) 494-0454 to speak with a specialist who will mail the appropriate forms to you and your doctor.  Hours are Monday – Friday 8 am – 8 pm (eastern).

Mesomark blood test may help Doctors measure a patient’s response to mesothelioma therapy

 Patients with mesothelioma (epithelial and biphasic types only) can now monitor progression of their disease with the MESOMARK blood test.  MESOMARK may help doctors measure a patient’s response to therapy.

The MESOMARK assay is a simple blood test that uses an Enzyme-Linked Immunosorbent Assay (ELISA) format, which quantitatively measures Soluble Mesothelin-Related Peptides (SMRP) in the blood of mesothelioma patients. SMRP is a biomarker that may be produced by mesothelioma cells that can be elevated in the serum (blood) of patients suffering from mesothelioma. Physicians may be better able to guide treatment options and monitor a patient’s disease by ordering regular MESOMARK tests. This test could be used in conjunction with regular PET/CT scans.

Not all patients will have elevated SMRP levels (above 1.0).  Talk with your doctor about your MESOMARK results to see if the test is appropriate for you.

What to do:
Your MESOMARK test must be order by a physician who is registered with Fujirebio Diagnostics.  Your physician will complete a one-page order form which you will take to an approved ARUP  laboratory so that the blood may be drawn. You must take this MESOMARK test request to a laboratory that is a member of the ARUP system. 

ARUP LABORATORIES IN CALIFORNIA ARE LISTED BELOW.  Please call ARUP at (801) 583-2787 to locate a laboratory near you:

ARUP Labs in the Los Angeles area include:

**UCLA (Recommended)**
www.ucla.edu/healthsci.html
200 Medical Plaza, Los Angeles, CA 90095
Specimen Collection Information: (310) 825-8080
Map: Click Here
Hours: Mon – Fri 6 am – 7 pm

California Hospital Medical Center
www.chmcla.org
1401 South Grand Ave., Los Angeles, CA 90015
(213) 748-2411
Map: Click Here

Cedars Sinai Medical Center
www.csmc.edu
8700 Beverly Blvd., Los Angeles, CA 90048
(310) 423-3277
Map: Click Here

Century City Doctors Hospital
www.ccdoctorshospital.com
2070 Century Park East , Los Angeles, CA 90067
(310) 772-4000
Map: Click Here

Glendale Adventist Medical Center
www.glendaleadventist.com
1509 Wilson Terrace, Glendale, CA 91206
(818) 409-8000
Map: Click Here

Pacific Alliance Medical Center
www.pamc.net
531 W College Street, Los Angeles, CA 90012-2315
(213) 624-8411
Map: Click Here

Simi Valley Hospital
2975 North Sycamore Drive, Simi Valley, CA 93065
(805) 955-6000
Map: Click Here

St. John’s Regional Medical Center
www.stjohnshealth.org
1600 North Rose Ave, Oxnard, CA 93030
(805) 988-2500
Lab Hours: Mon – Fri 7 am – 6 pm, Sat 8 am – 2 pm
Map: Click Here

St. Vincent Medical Center
www.stvincentmedicalcenter.com
2131 W 3rd St, Los Angeles, CA 90057
Cancer Treatment Center: (213) 484-7577
Laboratory: (213) 484-7931
Map: Click Here

Temple Community Hospital
www.templecommunityhospital.com
235 N. Hoover St., Los Angeles, CA 90004
(213) 382-7252
Map: Click Here

University of Southern California Norris Cancer Center
http://ccnt.hsc.usc.edu
1441 Eastlake Avenue, Los Angeles, California 90033-0804
(800) USC-CARE
Map: Click Here

University of Southern California University Hospital
www.uscuh.com
1500 San Pablo Street, Los Angeles, CA 90033
(323) 442-8500
Map: Click Here

White Memorial Medical Center
www.whitememorial.com
1720 Cesar E. Chavez Ave., Los Angeles, CA 90033
General Information: (323) 268-5000
Map: Click Here

ARUP Labs in the San Diego area include:

Laboratory Corporation of America
LabCorp, San Diego
13112 Evening Creek Drive South, San Diego, CA 92128
Toll Free: 800-859-6046
Local: 858-668-3700

Sharp Coronado
www.sharp.com
250 Prospect Place
Coronado, CA 92118
619-522-3600
Map: Click Here

All patients should go directly to the laboratory department for registration and testing. Lab services are available Monday through Friday, 7 am to 7 pm, and Saturday and Sunday, 7 am to 3 pm.

Scripps Clinic, Torrey Pines
www.scripps.org
10666 North Torrey Pines Road, La Jolla, CA 92037
(858) 455-9100
(858) 554-9552
Lab Hours: Monday – Friday, 6:30 a.m. – 5:00 p.m.
Map: Click Here

Located in the Anderson Outpatient Pavilion (AOP) on the Torrey Pines campus with Scripps Green Hospital near the Torrey Pines Golf Course. The blood draw lab is located near the main lobby of the AOP.

Veterans Affairs Medical Center, Chula Vista (South Bay)
835 3rd Avenue
Chula Vista, CA 91910
(619) 409-1600
Map: Click Here

Veterans Affairs Medical Center, Mission Valley
8810 Rio San Diego Drive
San Diego, CA 92108
619-400-5000
Map: Click Here

ARUP lab in Fresno:

Saint Agnes Medical Center
www.samc.com/UMAP.asp
1303 E. Herndon Ave.
Fresno, CA 93720
Lab Phone: (559) 450-3130
Map: Click Here
Lab hours: M-F 5:30 am – 6:30 pm, Sat 5:30 – noon; Closed Sundays

In Praise of Dr. Robert Cameron, by TC McNamara

John McNamara succumbed to mesothelioma in November of 2007, following a trip to Washington DC to speak with congress about asbestos exposure and the ravages of mesothelioma. John was treated by Dr. Robert Cameron.  The following is from the website www.thejohnmcnamarafoundation.org, a labor of love produced by John’s wife, TC McNamara. TC has been a tireless advocate for the complete eradication of asbestos in the United States and is well known in Washington DC for her tenacity, passion, and desire to help others suffering with mesothelioma.

Our Featured Doctor – Dr. Robert Cameron

It is our goal to feature a Mesothelioma specialist each month, to provide the Meso community with as much information about each specialist as we can. Hopefully we will provide you, the newcomer to this family with additional information about each doctor that you may not know, and hopefully we will also learn of the many new doctors out there that have provided excellent care, hope, and skill to this understaffed nightmare. So with much gratitude, respect, and love we honor Dr. Robert Cameron at UCLA as our first doctor. Besides for giving my family so much support and extended time with John, our hero we so appreciate his care and devotion, he showed and continues to show our family. Is the surgeon still involved?

We found that Dr. Cameron, followed us through every step he guided us as to what our next step was, and offered more hope than we could have imagined. His compassion to help meso patients and their families is so overwhelming, that when you meet him you find the man behind the title is a caring gentle soul.

Dr. Robert Cameron has been at the forefront of developing innovative therapies to extend the lives of hundreds of mesothelioma patients for more than two decades. His “less is more” philosophy guides his treatment approach while his resolve and compassion leads him to continue treating patients long after surgery.

Dr. Cameron’s Technique

As you have or will find, most doctors ask, why a tedious surgery known as a pleurectomy with decortication can save the lungs of mesothelioma patients. For eight hours, Dr. Cameron slowly peels tumor from the lung, diaphragm, and if necessary, pericardium, using mostly his fingers. He performs this longer, technically more involved surgery and is less compensated for the work financially than surgeons who sacrifice the lung in an extrapleural pneumonectomy.

Why?

Because he strongly believes this is the best option for mesothelioma patients. Because less is more in this case, because the lung is usually healthy, because people live better with both lungs, because no clinic trial has proven that removing the lung gives more life, and because it leaves doors open to seek further aggressive treatment when necessary.

Resolve

As Director of the Mesothelioma Program at the University of California at Los Angeles, Dr. Cameron advises patients on more than their surgical options, he continues to guide treatment for the rest of their lives. He developed a protocol for patients to successfully undergo radiation when their lung remains. He discusses the best chemotherapy protocols with oncologists and always tailors treatment to the individual. Most importantly, he recognizes the need to understand the mechanisms of mesothelioma so that treatment for the disease can improve. Dr. Cameron’s approach to commute mesothelioma from a fatal disease to a disease that can be maintained much like high blood pressure or diabetes has had promising results. No cure yet exists for any of these diseases, but continued research provides more options for patients. So when Dr. Cameron is not operating, he works in the laboratory to develop treatment such as interferon-alpha, a natural immune enhancement that helps prevent future recurrences. The John McNamara Foundation along with The Pacific Heart, Lung & Blood Institute is honored to support Dr. Cameron’s research aimed at developing more options and better treatment. His dedication is what ultimately provides hope for current patients and the generations of patients to come.

A Lesson in Courage from mesothelioma patient John MacNamara

Raising the advocacy bar:  John McNamara: Devoted husband, family man, and mesothelioma patient.

 

In November, 2007, John McNamara and his family attended a mesothelioma symposium in Washington, DC.  John was widely admired as a donor, spokesman, and leader for the patient community with a spirit that inspired everyone he met.  Not only did he need the symposium to spread his message – the symposium needed him to make a difference in the lives of other mesothelioma patients.  One month earlier, John was told that his cancer had returned and had metastasized to his spine. His physician advised him to stay home, but that was not an option for John.

 

“I met John shortly after he was diagnosed with mesothelioma,” said friend and attorney John Caron. “After five minutes you realize you’re spending time with a lifelong friend. He took on life with extraordinary energy, and his fight against mesothelioma was the same way. He didn’t know the meaning of rest.”

 

As planned, John joined his “band of mesothelioma brothers” in DC, advocating for increased medical research for this unrelenting disease. At his side, his beautiful children and his wife, TC, the love of his life for over thirty years.  A mesothelioma patient remarked: “If you spent one minute around this dynamic duo you felt that everything was possible.”

 

When he was first diagnosed with mesothelioma, local doctors soberly predicted that John only had a few months to live, and that aggressive treatments would be futile.  They were wrong.

 

“You know, if it wasn’t for Dr. Cameron, I wouldn’t be here,” John said during a break at the symposium. “I wouldn’t be anywhere. This cancer, I don’t have time for it. I have young children to raise and important things to do — like making sure they get good report cards.”

 

“John was an incredible warrior who approached mesothelioma like he approached life, with individuality, vigor and courage,” said Dr. Robert Cameron, thoracic surgeon at UCLA’s David Geffen School of Medicine who operated on John in November, 2005.

 

“He never acknowledged the suffering that he endured, even to the end.  John dedicated himself to helping others with the disease, even when his own life was in jeopardy.”

 

John knew that his own experience with mesothelioma was invaluable, and rather than dwell on his own situation he took every opportunity to support the cause of eradicating mesothelioma.  Whether meeting with legislators, encouraging patients, or interrogating researchers, he inspired those around him with his courage, good cheer and eternal hope.

 

“He was an empowering, courageous man,” says Linda Reinstein, executive director and co-founder of the Asbestos Disease Awareness Organization (ADAO). “He told me about his next great goal-to climb Half Dome. That sheer granite face that looks impossible, but can be conquered if you take it one step at a time.”  John hoped to conquer mesothelioma the same way.

 

On Thursday evening John joined the mesothelioma community on the steps of our nation’s Capitol, to participate in a candlelight vigil honoring those who had succumbed to the ravages of asbestos. His advocacy work along with the work of thousands of others had coalesced into something concrete: passage of U.S. Senator Patty Murray’s Ban Asbestos Act by the Senate.  It was a start.

 

The relentless pace and pressure of the symposium began to accumulate, and after two full days of advocacy and networking, John slowly began to weaken.  He decided to spend the next day “resting”, which translated into sightseeing with his family.  It was a struggle, but he did it.

 

However, late that afternoon, paralysis set in, and John was unable to leave his hotel room.  Conference attendee Dr. Robert Cameron attended to John in the McNamara’s hotel room. John’s philosophy was simple:  If mesothelioma would take him down, it would be in the service of the people who needed him, surrounded by those who loved him.

 

When John arrived back in Los Angeles, his condition was critical. Rushed to the emergency room at UCLA, he succumbed in the early morning hours, which brings to mind the wise words of a woman whose beloved husband was similarly felled: “When the end of mesothelioma comes as a shock, you know he has lived a courageous life.” Doctors believe that the likely cause of John’s death was pneumonia brought on by an aggressive infection.

 

TC McNamara has continued John’s legacy by establishing the John McNamara Foundation and she works tirelessly on behalf of mesothelioma patients and their families to make change.  She strongly supports the work of Dr. Robert Cameron, and we encourage you to visit her website: www.thejohnmcnamarafoundation.org

Taming the Chaos: Top Ten Pieces of Advice From The Linda Reinstein School of Hard Knocks

Linda Reinstein had no idea that she would help lead a global mission to enhance awareness and stop the production of the deadly carcinogen that took her husband’s life in 2006 — asbestos.  Reinstein is executive director and co-founder of the Asbestos Disease Awareness Organization (ADAO), a nonprofit, volunteer-run international organization that serves as a voice for all asbestos victims and their families. At the 2008 ADAO Asbestos Day Awareness conference, Linda shared the following advice:

Top Ten Pieces of Advice from the Linda Reinstein School of Hard Knocks:

  1. Remain informed and organized
  2. Trust your instincts
  3. Join a network of patients or caregivers
  4. Designate a 2nd advocate
  5. Live Life – Use your calendar
  6. Accept your “new normal”
  7. Build your expert medical team
  8. Understand your insurance coverage
  9. Evaluate your finances and legal documents
  10. Talk about your fears – to your spouse, family and friends.  Ask them to share theirs too.

Bonus:  “Most importantly, Live Well, Love Much, Laugh Often”

Please visit Linda’s website at www.asbestosdiseaseawareness.org and register for the 2009 ADAO Asbestos Awareness Day Conference in Manhattan Beach, California.  Dr. Robert Cameron will be speaking at the conference on March 28.

Dr. Cameron advocates a multimodal treatment approach for malignant pleural mesothelioma: Surgery, Chemotherapy, and Radiation to treat Malignant Pleural Mesothelioma

Since 2004, The combination of two FDA approved chemotherapy drugs, Pemetrexed (brand name: Alimta) and Cisplatin (no brand name) have been aggressively marketed as the “standard treatment” for malignant pleural mesothelioma.

HOWEVER,

Dr. Robert Cameron advocates a multimodal treatment approach for patients deemed eligible for surgery, consisting of: SURGERY, CHEMOTHERAPY, AND RADIATION

WHY?

  • Published data show that the combination of surgery, radiation, and chemotherapy is almost always associated with the longest survival times for pleural mesothelioma patients who are eligible for surgery. The median survival of patients who receive multimodal therapy varies from 16 to 22 months, depending on the staging, type of surgery, cell type, as well as other factors.
  • Surgery can remove gross mesothelioma tumor in up to 85% of patients (equivalent to a complete pathological response which is rare with cisplatin and pemetrexed. Adjuvant therapies, including chemotherapy and radiation can then be used to maintain a clinical remission. Furthermore, maintenance therapies, that can continue to suppress microscopic disease and forestall the tumor’s recurrence, as advocated by a few may provide even more long-term benefit.
  • Treating and managing mesothelioma as a chronic illness acknowledges the refractory (resistant to treatment) nature of the disease to all therapies and focuses on coping rather than curing.
  • Chemotherapy is an important weapon in the treatment of malignant pleural mesothelioma. However, in patients who are otherwise eligible for surgery, it is probably best used in a well planned multimodality therapy regimen.  Medical oncologists should advise their mesothelioma patients to consult with thoracic surgeons who have expertise in mesothelioma surgery, just as surgeons should advise their patients to consult with a qualified medical oncologist about the potential benefits of adjuvant (additional) chemotherapy and radiation. Patients who are evaluated and treated in a defined multimodality therapy regimen by a multidisciplinary team of physicians, including surgeons, medical oncologists, and radiation oncologists generally will be the most optimally managed and best served by their physicians. 

 

Mesothelioma Survivor Erwin Bergquist Donates $150,000 To PHLBI Research Efforts

When Erwin Bergquist, a three-year mesothelioma survivor and patient of Dr. Robert Cameron, came in for his regular check-up in May, 2008, he handed Dr. Cameron a check without saying a word.  The check was for $150,000.00 — the largest single gift from a patient in the history of PHLBI.

Jan and Erwin BergquistThe money was earmarked for Dr. Cameron’s IMIS research study, a PHLBI project that will create the world’s first online database of medical records for people with asbestos-related diseases.”

The database will allow researchers to examine anonymous medical records, spot trends, and develop research/prevention strategies based on a large amount of real-world medical data. “This is the first project of its kind for asbestos-related diseases,” says Dr. Cameron, “and Erwin’s donation puts us well over half-way to paying for the entire project, which will cost $250,000. We all owe him a debt of gratitude for this generous gift.”

Erwin gives back in so many  ways.  On his most recent visit to Dr. Cameron in mid-November, 2008, he was leaving the clinic when PHLBI Executive Director Amy Sriberg took him aside and asked a favor:  There was a newly diagnosed gentleman in the clinic, waiting to meet with Dr. Cameron.  He was clearly overwhelmed by his mesothelioma diagnosis and needed some help.  Would Erwin mind taking a moment to speak with this man?  Without hesitation, Erwin headed straight for the treatment room and spoke to the patient until Dr. Cameron arrived.  Email addresses and phone numbers were exchanged.  Erwin’s wife, Jan, waited patiently in the clinic lobby, fully aware of the impact of just one conversation with Erwin. 

Erwin Bergquist’s generosity extends far beyond his extraordinary donation. His kindness, compassion, and positive energy are gifts he shares with everyone fortunate enough to meet him.

Meet the Pacific Heart, Lung & Blood Institute’s Scientific Advisory Board

Scientific Advisory Board

PHLBI strives to fulfill our mission through collaborative utilization of the knowledge and talents of our Scientific Advisory Board which is responsible for directing our scientific and research activities. Our team of highly acclaimed physicians has already made substantial advancements in the treatment of heart, blood, and lung diseases.

ROBERT CAMERON, MD

Chief of Thoracic Surgery
West Los Angeles Veterans Medical Center
Director of the Mesothelioma Program
David Geffen School of Medicine at UCLA
Center for the Health Sciences, Room 64-128
10833 Le Conte Ave., Box 957313
Los Angeles, CA 90095-1741
Phone: (310) 794-7333
Email: rcameron@mednet.ucla.edu

Dr. Cameron has been at the forefront of developing innovative therapies for extending the lives of mesothelioma patients.

WARREN S. GRUNDFEST, MD, Chairman

Physician & Scientist
UCLA Bioengineering/Electrical Engineering
BOX 951600, 7523 BH
Los Angeles, CA 90095-1600
Email: warrenbe@seas.ucla.edu
http://www.bioeng.ucla.edu

Dr. Grundfest is widely recognized as a pioneer in the field of medical lasers and minimally invasive surgery.

 

PHILLIP HARBER, MD

Director of Occupational and Environmental Medicine Program
UCLA Department of Family Medicine
10833 Le Conte Avenue
Box 951683
Los Angeles, CA 90095-1683

Email: pharber@mednet.ucla.edu
Website: http://fm.mednet.ucla.edu/

Dr. Harber is trained and board certified in occupational (preventive) medicine, pulmonary diseases, and internal medicine.

 

DANIEL MILLER, MD

Attending Thoracic Surgeon, Emory University Healthcare
1365 Clifton Road NE
Atlanta, GA 30322

Email: daniel.miller@emoryhealthcare.org
Website: http://www.surgery.emory.edu/cardio_surgery/fac_d_miller.htm/

Dr. Miller is board certified in thoracic surgery and is an experienced mesothelioma surgeon.

GARY SCHILLER, MD

Chief, Therapeutic Hemapheresis
Physician, UCLA Oncology Center, Transfusion Medicine

UCLA Medical Center
BOX 951678, 42-121 CHS
Los Angeles, CA 90095-1678
Hematology/Oncology: (310) 206-6909
Therapeutic Hemapheresis: (310) 794-7177
Transfusion Medicine: (310) 825-4968
UCLA Oncology Center: (310) 206-6931

Dr. Schiller has conducted numerous studies which put into clinical trials new drugs and therapeutics which are developed in the laboratory for treatment of acute myelogenous leukemia (AML) and other hematologic malignancies.

JENNY T. MAO, MD

Associate Professor of Medicine
UCLA Pulmonary and Critical Care Medical Center
BOX 951690, 37-131 CHS Los Angeles, CA 90095-1690